Provided by Tiger Trade Technology Pte. Ltd.

CUTIA-B

1.020
-0.080-7.27%
Volume:960.80K
Turnover:993.19K
Market Cap:380.46M
PE:-0.99
High:1.280
Open:1.030
Low:1.000
Close:1.100
52wk High:9.190
52wk Low:0.740
Shares:373.00M
HK Float Shares:373.00M
Volume Ratio:0.58
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.030
ROE:-38.30%
ROA:-14.05%
PB:0.46
PE(LYR):-0.99
PS:0.98

Loading ...

Cutia Therapeutics - Nmpa Accepts Biologics License Application for Cu-20101 (Botulinum Toxin Type A) in China

THOMSON REUTERS
·
Sep 03

Cutia Therapeutics Posts HY Loss of Rmb180.4 MLN

Reuters
·
Aug 31

Cutia: Interim Loss Narrows to RMB180.40 Million on 5.4% Revenue Decline, Cost Controls & Pipeline Advances Highlight H1 2026

Bulletin Express
·
Aug 31

CUTIA-B posts narrower interim net loss of RMB 180 million

Stock News
·
Aug 31

Cutia Therapeutics - Hy Revenue Rmb62.7 Mln

THOMSON REUTERS
·
Aug 31

Cutia Therapeutics - Board Does not Recommend Payment of Interim Dividend

THOMSON REUTERS
·
Aug 31

Cutia FY26 H1 Net Loss Narrows 24.65% to RMB 180.4 Million; Revenue Falls 5.4% to RMB 62.7 Million

Reuters
·
Aug 31

Cutia Therapeutics Sets 31 Aug 2026 Board Meeting to Approve H1 2026 Results and Assess Interim Dividend

Bulletin Express
·
Aug 19

Cutia Therapeutics (HKG:2487): Are Analysts Optimistic?

Simply Wall St.
·
Aug 11

CUTIA-B Issues 9.803 Million Shares Under Share Scheme

Stock News
·
Jul 02

Cutia Therapeutics Next-day Disclosure Return Reports 9,803,014 New Shares Issued on HKEX

Reuters
·
Jul 02

Cutia Therapeutics Secures Full Shareholder Support at 2026 AGM, Obtains Fresh Issue and Buy-back Mandates

Bulletin Express
·
Jun 26

Cutia Therapeutics AGM Resolutions Passed in Shareholder Vote

Reuters
·
Jun 26

CUTIA-B Records HK$91.56 Million Share Transfer, Representing 7.07% of Holdings

Stock News
·
Jun 05

Cutia Therapeutics Holds Share Base Steady in May 2026, Confirms Sufficient Public Float

Bulletin Express
·
Jun 04

CUTIA-B Keeps Share Count Flat in April; 230,110 Options and 2.06 Million Share Awards Forfeited

Bulletin Express
·
May 07

CUTIA-B (02487) Receives NMPA Approval for CU-30101, a Topical Lidocaine-Tetracaine Cream

Stock News
·
May 07

Cutia-B obtains NMPA marketing nod for CU-30101 lidocaine-tetracaine topical anesthetic

Bulletin Express
·
May 07

Cutia Therapeutics says NMPA approves CU-30101 topical lidocaine-tetracaine cream

Reuters
·
May 07

Cutia Therapeutics - Cu-30101 Obtains Drug Marketing Authorization by Nmpa in China

THOMSON REUTERS
·
May 07